MDSCs promote tumor epithelial–mesenchymal transformation (EMT) by expressing factors, such as TGFβ, IL-6, hepatocyte growth factor (HGF), and high mobility group binding (HMGB)-1, which makes tumors exhibit aggressive phenotypes with high migration ability [16]. The gene discussed is TGFB1; the disease is neoplasm.